• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动与糖尿病患者终末期肾脏疾病风险的关系。

Association between atrial fibrillation and risk of end-stage renal disease among adults with diabetes mellitus.

机构信息

Department of Medical Research, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan.

Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.

出版信息

PLoS One. 2022 Aug 26;17(8):e0273646. doi: 10.1371/journal.pone.0273646. eCollection 2022.

DOI:10.1371/journal.pone.0273646
PMID:36026496
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9417190/
Abstract

Diabetes mellitus (DM) is an important risk factor in patients with end-stage renal disease (ESRD). DM is associated with the development of cardiovascular diseases, such as atrial fibrillation (AF), due to poor glycemic control. However, few studies have focused on the risk of developing ESRD among DM patients with and without AF. This study evaluated ESRD risk among DM patients with and without AF in Taiwan. Data were retrieved from one million patients randomly sampled from Taiwan's National Health Insurance Research Database, including 6,105 DM patients with AF propensity score-matched with 6,105 DM patients without AF. Both groups were followed until death, any dialysis treatment, or December 31, 2013, whichever occurred first. AF was diagnosed by a qualified physician according to the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM), using the diagnostic code 427.31. Patients aged <20 years or diagnosed with ESRD before the index date were excluded. A Cox proportional hazard regression model was used to calculate the relative ESRD risk. Among DM patients, those with AF have more comorbidities than those without AF. We also found a 1.18-fold (95% confidence interval [CI]: 1.01-1.46) increase in ESRD risk among patients with AF compared with those without AF. In addition, DM patients with hypertension, chronic kidney disease (CKD), or higher Charlson Comorbidity Index scores also have significantly increased ESRD risks than those without these complications. A 1.39-fold (95% CI: 1.04-1.86) increase in risk was observed for patients with AF among the non-CKD group. Our findings suggest that patients with DM should be closely monitored for irregular or rapid heart rates.

摘要

糖尿病(DM)是终末期肾病(ESRD)患者的一个重要危险因素。由于血糖控制不佳,DM 与心血管疾病的发生有关,如心房颤动(AF)。然而,很少有研究关注 DM 患者中有无 AF 的 ESRD 发病风险。本研究评估了台湾地区 DM 患者中有无 AF 的 ESRD 发病风险。数据来自台湾全民健康保险研究数据库的 100 万名患者随机抽样,包括 6105 例有 AF 倾向的 DM 患者和 6105 例无 AF 的 DM 患者,进行倾向性评分匹配。两组患者均随访至死亡、任何透析治疗或 2013 年 12 月 31 日,以先发生者为准。AF 由合格医师根据国际疾病分类,第 9 版,临床修订版(ICD-9-CM),使用诊断代码 427.31 进行诊断。排除年龄<20 岁或指数日期前诊断为 ESRD 的患者。使用 Cox 比例风险回归模型计算相对 ESRD 风险。在 DM 患者中,AF 患者比无 AF 患者有更多的合并症。我们还发现,与无 AF 患者相比,AF 患者的 ESRD 风险增加了 1.18 倍(95%置信区间 [CI]:1.01-1.46)。此外,患有高血压、慢性肾脏病(CKD)或更高 Charlson 合并症指数评分的 DM 患者与无这些并发症的患者相比,ESRD 风险显著增加。在非 CKD 组中,AF 患者的风险增加了 1.39 倍(95%CI:1.04-1.86)。我们的研究结果表明,DM 患者应密切监测不规则或快速的心率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d0/9417190/c38a1695730e/pone.0273646.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d0/9417190/a471fc69fa58/pone.0273646.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d0/9417190/fa94aca6abed/pone.0273646.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d0/9417190/c38a1695730e/pone.0273646.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d0/9417190/a471fc69fa58/pone.0273646.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d0/9417190/fa94aca6abed/pone.0273646.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d0/9417190/c38a1695730e/pone.0273646.g003.jpg

相似文献

1
Association between atrial fibrillation and risk of end-stage renal disease among adults with diabetes mellitus.心房颤动与糖尿病患者终末期肾脏疾病风险的关系。
PLoS One. 2022 Aug 26;17(8):e0273646. doi: 10.1371/journal.pone.0273646. eCollection 2022.
2
Increased risk of atrial fibrillation in end-stage renal disease patients on dialysis: A nationwide, population-based study in Taiwan.台湾地区一项基于全国人口的研究:透析治疗的终末期肾病患者心房颤动风险增加。
Medicine (Baltimore). 2016 Jun;95(25):e3933. doi: 10.1097/MD.0000000000003933.
3
Incidence and risk factors for new-onset atrial fibrillation among patients with end-stage renal disease undergoing renal replacement therapy.终末期肾病患者接受肾脏替代治疗后新发心房颤动的发生率及相关危险因素。
Kidney Int. 2015 Jun;87(6):1209-15. doi: 10.1038/ki.2014.393. Epub 2015 Jan 14.
4
Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease.成人慢性肾脏病患者的阵发心房颤动与终末期肾病风险。
Circulation. 2013 Feb 5;127(5):569-74. doi: 10.1161/CIRCULATIONAHA.112.123992. Epub 2012 Dec 28.
5
Comparison of incidence of acute kidney injury, chronic kidney disease and end-stage renal disease between atrial fibrillation and atrial flutter: real-world evidences from a propensity score-matched national cohort analysis.比较心房颤动和心房扑动之间急性肾损伤、慢性肾脏病和终末期肾病的发生率:来自倾向评分匹配全国队列分析的真实世界证据。
Intern Emerg Med. 2019 Oct;14(7):1113-1118. doi: 10.1007/s11739-019-02089-1. Epub 2019 May 9.
6
The risk trajectory of different cardiovascular morbidities associated with chronic kidney disease among patients with newly diagnosed diabetes mellitus: a propensity score-matched cohort analysis.新诊断糖尿病患者中与慢性肾脏病相关的不同心血管疾病发病率的风险轨迹:倾向评分匹配队列分析。
Cardiovasc Diabetol. 2021 Apr 24;20(1):86. doi: 10.1186/s12933-021-01279-6.
7
Impact of HCV Infection on Diabetes Patients for the Risk of End-Stage Renal Failure.丙型肝炎病毒感染对糖尿病患者发生终末期肾衰竭风险的影响。
Medicine (Baltimore). 2016 Jan;95(3):e2431. doi: 10.1097/MD.0000000000002431.
8
The CHADS-VASc score predicts chronic kidney disease among patients with atrial fibrillation.CHADS-VASc 评分可预测房颤患者的慢性肾脏病。
Int Urol Nephrol. 2020 Aug;52(8):1523-1531. doi: 10.1007/s11255-020-02514-x. Epub 2020 Jun 1.
9
Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.需要透析的终末期肾病房颤患者缺血性卒中的发病率及预测
Heart Rhythm. 2014 Oct;11(10):1752-9. doi: 10.1016/j.hrthm.2014.06.021. Epub 2014 Jun 18.
10
Continuation of statin therapy and a decreased risk of atrial fibrillation/flutter in patients with and without chronic kidney disease.他汀类药物治疗的延续与慢性肾脏病患者和非慢性肾脏病患者心房颤动/扑动风险降低的关系。
Atherosclerosis. 2014 Jan;232(1):224-30. doi: 10.1016/j.atherosclerosis.2013.11.036. Epub 2013 Nov 19.

本文引用的文献

1
Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort study.2 型糖尿病患者发生心房颤动的风险以及与血糖控制和肾功能的关系:一项瑞典队列研究。
Cardiovasc Diabetol. 2020 Jan 18;19(1):9. doi: 10.1186/s12933-019-0983-1.
2
Disease-treatment interactions in the management of patients with obesity and diabetes who have atrial fibrillation: the potential mediating influence of epicardial adipose tissue.肥胖和糖尿病合并心房颤动患者管理中的疾病-治疗相互作用:心外膜脂肪组织的潜在中介影响。
Cardiovasc Diabetol. 2019 Sep 24;18(1):121. doi: 10.1186/s12933-019-0927-9.
3
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition.
2019 年全球及各区域糖尿病患病率估算值及 2030 年和 2045 年预测值:国际糖尿病联盟糖尿病地图集(第 9 版)的结果。
Diabetes Res Clin Pract. 2019 Nov;157:107843. doi: 10.1016/j.diabres.2019.107843. Epub 2019 Sep 10.
4
Diabetes mellitus, blood glucose and the risk of heart failure: A systematic review and meta-analysis of prospective studies.糖尿病、血糖与心力衰竭风险:前瞻性研究的系统评价和荟萃分析。
Nutr Metab Cardiovasc Dis. 2018 Nov;28(11):1081-1091. doi: 10.1016/j.numecd.2018.07.005. Epub 2018 Jul 25.
5
High overall cardiovascular risk and mortality in patients with atrial fibrillation and diabetes: A nationwide report.心房颤动合并糖尿病患者的总体心血管风险和死亡率:一项全国性报告。
Diab Vasc Dis Res. 2018 Jan;15(1):31-38. doi: 10.1177/1479164117735013. Epub 2017 Oct 20.
6
Modifiable Risk Factors and Atrial Fibrillation.可改变的风险因素与心房颤动。
Circulation. 2017 Aug 8;136(6):583-596. doi: 10.1161/CIRCULATIONAHA.116.023163.
7
The Relationship Between Atrial Fibrillation and Chronic Kidney Disease : Epidemiologic and Pathophysiologic Considerations for a Dual Epidemic.心房颤动与慢性肾脏病的关系:两种流行病的流行病学和病理生理学考量
J Atr Fibrillation. 2012 Jun 15;5(1):442. doi: 10.4022/jafib.442. eCollection 2012 Jun-Jul.
8
Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI).血液透析患者心房颤动及抗栓治疗的患病率:维也纳血液透析患者心房颤动和血栓栓塞调查(VIVALDI)的横断面结果
PLoS One. 2017 Jan 4;12(1):e0169400. doi: 10.1371/journal.pone.0169400. eCollection 2017.
9
Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis.心房颤动与心血管疾病、肾脏疾病和死亡风险:系统评价和荟萃分析。
BMJ. 2016 Sep 6;354:i4482. doi: 10.1136/bmj.i4482.
10
A Bayesian Approach to Identifying New Risk Factors for Dementia: A Nationwide Population-Based Study.一种用于识别痴呆症新风险因素的贝叶斯方法:一项基于全国人口的研究。
Medicine (Baltimore). 2016 May;95(21):e3658. doi: 10.1097/MD.0000000000003658.